Explore the latest in venous thromboembolism, including the latest in risk prediction and management with newer oral anticoagulants.
This cohort study examines the performance of risk assessment scores among US patients with acute pulmonary embolism.
This cohort study assesses the prevalence of lupus anticoagulant (LA) positivity in patients with coronavirus disease 2019 (COVID-19) and examines the association of LA positivity with patient outcomes.
This JAMA Clinical Guidelines Synopsis summarizes the European Society of Cardiology’s 2019 guidelines for diagnosis and management of acute pulmonary embolism.
This cohort study evaluates the association of inferior vena cava (IVC) filters with the development of pulmonary embolism (PE) in patients with cancer and deep venous thrombosis (DVT).
This randomized clinical trial investigates the safety and efficacy of oral apixaban vs subcutaneous enoxaparin for postoperative thromboprophylaxis in patients with gynecologic cancer.
This cohort study examines the association of thromboelastographic results with hypercoagulability among patients with coronavirus disease 2019 who have been admitted to an intensive care unit.
This cohort study investigates whether emergency case status is independently associated with venous thromboembolism compared with elective case status and tests the hypothesis that emergency cases would have a higher risk of venous thromboembolism.
This case series reports a systematic assessment of deep vein thrombosis among patients in an intensive care unit in France with severe coronavirus disease 2019 (COVID-19).
A 58-year-old woman presents with no relevant medical history with syncope, elevated troponin and D-dimer levels, and multiple large bilateral pulmonary emboli. What would you do next?
This systematic review and meta-analysis of randomized clinical trials assesses the effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip replacement and total knee replacement.
This case report describes coronary-to-pulmonary artery collateralizations in chronic thromboembolic pulmonary hypertension.
This randomized clinical trial investigates the effect of a rehabilitation intervention, comprising an 8-week home-based exercise program and nurse consultations, on physical capacity and patient-reported outcomes among patients with acute pulmonary embolism.
This case-crossover study assesses whether testosterone therapy is associated with short-term risk of venous thromboembolism in men with and without hypogonadism.
This phase 2 clinical noninferiority trial compared 4 doses of postoperative osocimab, a monoclonal antibody against factor XI, vs enoxaparin and apixiban on venous thromboembolism incidence among patients undergoing knee replacement.
A 59-year-old man taking warfarin for recurrent VTE has a point-of-care (POC) international normalized ratio (INR) value of 3.7 (target 2.0 to 3.0). What would you do next?
This randomized clinical trial conducted in 9 countries compares the use of dabigatran with warfarin in stroke prevention among patients who just experienced cerebral venous thrombosis.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: